Principles of HIV drug resistance for clinical management in South Africa. HIV Nursing Matters, 3(4): 46-51 (2012).

Publication Latest Publications

Title: Principles of HIV drug resistance for clinical management in South Africa
Authors: Stott K, Michel J, de Oliveira T.
Journal: HIV Nursing Matters,3(4):46-51 (2012)


The rapid scale-up of antiretroviral therapy (ART) during the past decade has led to dramatic reductions in HIVrelated morbidity and mortality. Efforts are now focused on maintaining virological suppression of patients on first line ART, detecting treatment failure and switching to second-line regimens where necessary.

A major threat to sustaining the positive impacts of ART is the increasing issue of drug resistance. Drug resistance may be primary (transmitted), whereby a person is infected by a strain of HIV that is not fully susceptible to antiretroviral medications (ARVs), or secondary (acquired), whereby a person develops resistance to ARVs over time. In South Africa, the level of primary resistance has been below 5% for the last decade and so this article will focus on the more pressing problem of secondary resistance.

In Southern Africa, routine viral-load monitoring is recommended to identify treatment failure but it is often not done with sufficient frequency, nor reacted to appropriately. There can be a reluctance to switch patients to second-line therapy, in spite of clear guidelines. This is in part because of a lack of certainty regarding the reason for treatment failure ? whether it is due to poor patient adherence, the development of drug resistance, or a combination of these issues. Nonetheless, patients who continue taking a failing ART regimen are at risk of developing resistance to those medications. This article reviews the South African guidelines for viral load monitoring and regimen switch and introduces basic concepts of drug resistance for nurses and health care workers. The information presented here is useful to practitioners throughout Southern Africa as most HIV epidemics in the region are dominated by the same HIV subtype (HIV-1 subtype C), and drug resistance develops by similar mechanisms.

Download: Full text paper

Citation: Stott K, Michel J, de Oliveira T. Principles of HIV drug resistance for clinical management in South Africa HIV Nursing Matters,3(4):46-51 (2012).

Summary PowerPoint Presentation

Stott K, Michel J, de Oliveira T. Principles of HIV drug resistance for clinical management in South Africa .HIV Nursing Matters,3(4):46-51 (2012)

Download: Slide Presentation

This summary presentation presents the tables, images and conclusions from the paper. Slides are openly accessible and can be used in other presentations, given reference details are displayed.

Printed and Online Media Coverage


UKZN Research Centres Collaborate to Celebrate World AIDS Day

UKZN - 2012-11-29

The Health Economics and HIV and AIDS Research Division (HEARD) in collaboration with CAPRISA, SATuRN/Africa Centre and the University of KwaZulu-Natal Press hosted Getting to Zero: Showcasing KZN Research on HIV and AIDS on 14 November at the KZNSA Gallery.

High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients
Journal: Clinical Infectious Diseases (2017)

Virological Outcomes of Second-line Protease Inhibitor?Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis
Journal: Clinical Infectious Diseases (2017)

CD4+ T-cell count may not be a useful strategy to monitor antiretroviral therapy response in HTLV-1/HIV co-infected patients
Journal: Current HIV Research (2017)
All publications...

Page design updated by Tulio de Oliveira, 2013